Downstream processing operations have a direct impact on biopharma product quality and cost. Therefore, optimization of downstream biologics purification steps is not surprisingly focused on ...

Alternatives to Traditional Unit Operations Are Now Available to Alleviate Very Real Logjams Due to the complexity of therapeutic protein purification, downstream bioprocess bottlenecks can arise from ...

Over two-thirds of biopharmaceutical manufacturers now report that their facility is experiencing capacity bottlenecks due to downstream processing. A number of factors continue to converge to create ...

GÖTTINGEN, Germany, January 05, 2023 / B3C newswire / --The life science group Sartorius extended a strategic collaboration partnership agreement with RoosterBio Inc. (RoosterBio) to address ...

In a recent study posted to the bioRxiv* preprint server, researchers assessed the impact of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) entry route on downstream cellular and ...

Simple, inexpensive real-time analytics are urgently needed for high value products. Downstream processing operations have a direct impact on biopharma product quality and cost. Therefore, ...

The cell and gene therapy industry will greatly benefit from access to robust, scalable, end-to-end solutions for the production and characterization of native and engineered exosome therapeutics.” — ...